Factors influencing the prognosis of PC patients included gender, tumor size, pTNM stage, T stage, lymphatic metastasis, distant metastasis, vascular invasion, and PELI1 immunohistochemistry (IHC) staining score. This evidence concerns the gene PELI1 and neoplasm.